JH9-33650-08555
3 vaccinations
3 coded responses
18 check-ins
3 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 600 / IL
- Registered
- 2022-11-12
- Relationship
- Child or adolescent in my care
- Guardian
- GWQ-59185-42741
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-10-11
Dose 1 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-12
Registered in v-safe
-
2022-11-12
Dose 2 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-12
Health check-in — day 0, dose 2, under 3Feeling: Good · Site: Redness, Swelling/hardness · NoneUnder 3 check-in
-
2022-11-13
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Redness, Swelling/hardness · NoneUnder 3 check-in
- 2022-11-14
- 2022-11-15
- 2022-11-16
-
2022-11-17
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Runny nose, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-18
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-11-19
- 2022-11-27
- 2022-12-03
- 2022-12-10
- 2022-12-19
-
2022-12-24
Health check-in — day 42, dose 2, under 3Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Congestion, runny nose, coughUnder 3 check-in · check-in free text available
-
2022-12-24
Call case (no matching report) — SuccessfulNot applicable - Accidental Reporting
-
2022-12-28
Call successfulNot applicable - Accidental Reporting
- 2023-02-11
-
2023-02-22
Dose 3 — Pfizer-BioNTech
- 2023-03-22
- 2023-03-29
- 2023-04-05
-
2023-05-24
Survey response — 3 months, dose 3, under 3MedDRA: Conjunctivitis, Ear infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
- 2023-05-24
- 2023-05-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-10-11 | Pfizer-BioNTech | Flu |
| 2 | 2022-11-12 | Pfizer-BioNTech | Flu |
| 3 | 2023-02-22 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Runny nose, congestion
Systemic reaction (other): Runny nose
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Congestion, runny nose, cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release